Cadrenal Therapeutics Inc (CVKD)
0.4905
+0.03
(+5.48%)
USD |
NASDAQ |
May 03, 16:00
0.4926
0.00 (0.00%)
After-Hours: 20:00
Cadrenal Therapeutics Shareholders Equity (Quarterly): 7.692M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.692M |
| September 30, 2023 | 8.746M |
| June 30, 2023 | 3.176M |
| March 31, 2023 | 4.065M |
| Date | Value |
|---|---|
| December 31, 2022 | -5.551M |
| September 30, 2022 | -1.180M |
| June 30, 2022 | -0.6708M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-5.551M
Minimum
Dec 2022
8.746M
Maximum
Sep 2023
2.325M
Average
3.176M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Tenax Therapeutics Inc | 8.098M |
| Syra Health Corp | 4.013M |
| Minerva Neurosciences Inc | -28.46M |
| Adverum Biotechnologies Inc | 83.47M |
| Genprex Inc | 7.416M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.519M |
| Total Liabilities (Quarterly) | 0.8269M |